Luminist Capital’s Merck MRK Stock Holding History

Luminist Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.45K	Buy	+58	New	+$6.79K	0.01%	231
2026 Q1	–	Sell	-17	Closed	-$1.79K	–	215
2025 Q4	$1.79K	Buy	+17	New	+$1.6K	﹤0.01%	230

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Luminist Capital's MRK Position: Q2 2026 in Review

Luminist Capital opened a new position in Merck (MRK) in Q2 2026: 58 shares worth $7.45K. The stake represents 0.01% of the portfolio and ranks #231 among its holdings. This is a return to the name: Luminist Capital previously reported a position in MRK as recently as Q4 2025.

Luminist Capital first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Luminist Capital held 58 shares of Merck worth $7.45K as of Q2 2026.
Merck was a new Luminist Capital position in Q2 2026.
Merck made up 0.01% of Luminist Capital's portfolio in Q2 2026, its #231 holding.
Luminist Capital first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.